Phenformin combines with selumetinib in targeting KRAS mutant non-small cell lung cancer cells with alternative LKB1 status.
Jun Zhang
No relevant relationships to disclose
Dongsheng Wang
No relevant relationships to disclose
Guoqing Qian
No relevant relationships to disclose
Fakeng Liu
No relevant relationships to disclose
Mohammad Aminur Rahman
No relevant relationships to disclose
Sreevinas Nannapaneni
No relevant relationships to disclose
Xu Wang
No relevant relationships to disclose
Xianghong Peng
No relevant relationships to disclose
Zhuo Georgia Chen
No relevant relationships to disclose
Kwok-Kin Wong
No relevant relationships to disclose
Fadlo Raja Khuri
No relevant relationships to disclose
Wei Zhou
No relevant relationships to disclose
Dong Moon Shin
No relevant relationships to disclose